HomeIMRX • NASDAQ
Immuneering Corp
add
$9.01
11.65%
After Hours:(0.44%)+0.040
$9.05
Closed: Sep 18, 6:54:18 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 14.76M | -1.05% |
Net income | -14.43M | -2.51% |
Net profit margin | — | — |
Earnings per share | -0.40 | 14.89% |
EBITDA | -14.67M | 1.01% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.36M | -55.87% |
Total assets | 40.06M | -48.04% |
Total liabilities | 11.12M | 3.14% |
Total equity | 28.94M | — |
Shares outstanding | 36.32M | — |
Price to book | 10.09 | — |
Return on assets | -81.32% | — |
Return on capital | -93.57% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -14.43M | -2.51% |
Cash from operations | -9.45M | 18.04% |
Cash from investing | -2.12K | -100.04% |
Cash from financing | -61.96K | — |
Net change in cash | -9.51M | -45.00% |
Free cash flow | -4.27M | 37.07% |
Previous close
$8.07
Day range
$8.16 - $9.05
Year range
$1.10 - $9.34
Market cap
375.01M USD
Avg Volume
972.30K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2008
Website
Employees
54
